Tegaserod in the treatment of irritable bowel syndrome with constipation

Author： Saad Richard   Chey William D  

Publisher： Future Medicine

ISSN： 1745-5057

Source： Women's Health, Vol.2, Iss.1, 2006-01, pp. : 29-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: fibre and FODMAPs in constipation and irritable bowel syndrome

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 3, 2015-08 ,pp. : 383-384

John Wiley & Sons Inc

Access to resources Recommend Favorite

A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation

By Johnston Jeffrey M.   Shiff Steven J.   Quigley Eamonn M.M.  

Current Medical Research and Opinion, Vol. 29, Iss. 2, 2013-02 ,pp. : 149-160

Informa Healthcare

Access to resources Recommend Favorite

Insights into the Pathophysiology and Mechanisms of Constipation, Irritable Bowel Syndrome, and Diverticulosis in Older People

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 48, Iss. 9, 2000-09 ,pp. : 1142-1150

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: differentiating chronic idiopathic constipation from constipation‐predominant irritable bowel syndrome – possible and important? – Authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 12, 2015-06 ,pp. : 1300-1300

John Wiley & Sons Inc

Access to resources Recommend Favorite

Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population‐based study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 9, 2015-05 ,pp. : 856-866

John Wiley & Sons Inc

Access to resources Recommend Favorite